Yeni Zelanda'da Covid 19’a Bakış Açısı

Year 2020, Volume: 4 Issue: 2, 98 - 106, 31.08.2020

Aylin Çakır Nilay Gemlik

https://doi.org/10.34084/bshr.746521

Abstract

COVID-19, 2019’un aralık ayında Çin’in Vuhan kentinde ortaya çıkan, solunum yolu belirtileri ile gelişen ve dünya genelini etkisi altına alan salgın bir hastalıktır. Dünya çapında pek çok ülkeyi etkilemesi ve bulaş hızının yüksek olması sebebiyle ülkeler çeşitli tedbirler almak durumunda kalmıştır. Doğru tedbirlerin alınması ise hastalıkla mücadele konusunda önem teşkil etmektir. Küresel düzeyde hızla yayılım gösteren koronavirüs nedeniyle her ülkenin önlemler alarak virüsün yayılmasının önüne geçmesi bu noktada önem teşkil etmektedir.

Bu makalede koronavirüsün genel özellikleri, epidemiyolojisi, inkübasyon süresi, klinik özellikleri, bulaş yolu, temel vaka üreme sayısı ve fatalite hızı incelenmiştir. Aynı zamanda COVİD-19 ile mücadele eden Yeni Zelanda’nın, uygulamış olduğu eylem planları, hızlı vaka tespitiyle temas takibi ve erken uyarı sistemi incelenmiştir.

Bu çalışmanın amacı, güncel veriler ve literatür ışığında koronavirüsü genel olarak incelemekle beraber koronavirüsün yayılışına etki eden faktörleri ortaya koymak ve Yeni Zelanda’nın koronavirüsle nasıl başa çıktığını, bu süreçte ne gibi planlar uyguladığını ve bu planların vakalar ile hastalığın yayılışına nasıl etki ettiğini incelemek amacı ile yapılmıştır.

Keywords

COVID-19, coronavirüs, Yeni Zelanda

Supporting Institution

Yok

The View of COVID-19 in New Zealand

Abstract

COVID-19 is an epidemic disease that occurs in Wuhan, China in December 2019, develops with respiratory symptoms and affects the world. Due to the fact that it affects many countries worldwide and the transmission speed is high, countries have had to take various measures. Taking the right measures is important to combat the disease. At this point, it is important for every country to take precautions to prevent the spread of the virus due to the rapidly spreading coronavirus at the global level.

In this article, general characteristics, epidemiology, incubation period, clinical features, transmission route, basic case reproduction number and fatality rate of coronavirus were investigated. At the same time, action plans, contact tracking with rapid case detection and early warning system implemented by New Zealand, which struggled with COVID-19, were examined.

The aim of this study is to examine the coronavirus in general in the light of current data and literature, to reveal the factors affecting the spread of coronavirus, and to examine how New Zealand copes with coronavirus, what plans it has in this process, and how these plans affect the spread of the disease with cases.

Keywords

COVID-19, Coronavirus, New Zealand

References

• 1.T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü, 2019-nCoV Hastalığı Sağlık Çalışanları Rehberi. 30 Ocak 2020. Ankara.
• 2. Heimdal I, Moe N, Krokstad S, et al. Human Coronavirus in HospitalizedChildrenWithRespiratoryTractInfections: A 9-Year Population-BasedStudyFromNorway. J InfectDis. 2019;219:8:1198-206.
• 3. https://covid19bilgi.saglik.gov.tr/tr/ (Erişim Tarihi 22.04.2020)
• 4.Zhu N, Zhang D, Wang W, et al. A NovelCoronavirusfromPatientswithPneumonia in China, 2019. N Engl J Med. 2020.
• 5. https://covid19.govt.nz/alert-system/covid-19-alert-system/#level-1-prepare (Erişim Tarihi, 19.04.2020)
• 6. https://www.health.govt.nz/publications?page=1, Erişim Tarihi 22.04.2020
• 7.Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infectionfrom an AsymptomaticContact in Germany. N Engl J Med. 2020.
• 8.World HealthOrganization. NovelCoronavirusSituationReports. https://www.who.int/emergencies/diseases/novel-Coronavirus-2019/situation-reports. Erişim Tarihi: 26.04.2020
• 9. WHO. Coronav¬rusd¬ease(COVID-19) s¬tuat¬on reports.2020. https://www.who.-nt/docs/default-source/coronav¬ruse/s¬tuat¬on-reports/20200122-s¬trep-2-2019-ncov.pdf (Erişim Tarihi 26.04.2020)
• 10.Chen ZM, Fu JF, Shu Q, et al. Diagnosisandtreatmentrecommendationsforpediatricrespiratoryinfectioncausedbythe 2019 novelCoronavirus. World J Pediatr. 2020.
• 11.Lu R, Zhao X, Li J, et al. Genomiccharacterisationandepidemiology of 2019 novelCoronavirus: implicationsforvirusoriginsandreceptorbinding. Lancet. 2020.
• 12.Malik YS, Sircar S, Bhat S, et al. EmergingnovelCoronavirus (2019-nCoV) -Currentscenario, evolutionaryperspectivebased on genomeanalysisandrecentdevelopments. Vet Q. 2020: 1-12.
• 13.Chan JF, Yuan S, Kok KH, et al. A familialcluster of pneumoniaassociatedwiththe 2019 novelCoronavirusindicatingperson-to-persontransmission: a study of a familycluster. Lancet. 2020.
• 14. Wong CM, Cregeen SJJ, Ajami NJ, Petrosino JF. Evidence of recombination in coronavirusesimplicatingpangolinorigins of nCoV-2019. bioRxiv. 2020:937862.
• 15. https://www.beehive.govt.nz/search?query=covid%2019&page=5 (Erişim Tarihi, 29.04.2020)
• 16. https://www.cnnturk.com/dunya/yeni-zelandada-ilk-koronavirus-vakasi-tespit-edildi (Erişim Tarihi, 29.04.2020)
• 17. L¬ Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. EarlyTransm¬ss¬onDynam¬cs¬n Wuhan, Ch¬na, of NovelCoronav¬rus-InfectedPneumon¬a. N Engl J Med. 2020;382(13):1199-207.
• 18. WHO. Coronav¬rusd¬ease(COVID-19) s¬tuat¬on reports.2020.https://www.who.¬nt/docs/ default-source/coronav¬ruse/s¬tuat¬on-reports/20200219-s¬trep-30-cov¬d-
• 19.pdf?sfvrsn=3346b04f_2 (Er¬işim Tarihi 26.04.2020).
• 19. Lauer SA, Grantz KH, B¬ Q, Jones FK, Zheng Q, Mered¬th HR, et al. e Incubat¬onPer¬od of Coronav¬rusD¬sease 2019 (COVID-19) FromPubl¬clyReportedConf¬rmedCases: Est¬-mat-onandAppl¬cat¬on. AnnInternMed. 2020.
• 20. Ch¬u WK, Cheung PC, Ng KL, Ip PL, Sugunan VK, Luk DC, et al. Severe acuteresp-ratorysyndrome¬n ch¬ldren: exper¬ence¬n a reg¬onalhosp¬tal¬n Hong Kong. Ped¬atrCr¬tCareMed. 2003;4(3):279-83.
• 21.Chen H, Guo J, Wang C, et al. Clinicalcharacteristicsandintrauterineverticaltransmissionpotential of COVID-19 infection in nine pregnantwomen: a retrospectivereview of medicalrecords. wwwthelancetcom. 2020.
• 22.Wang D, Hu B, Hu C, et al. ClinicalCharacteristics of 138 HospitalizedPatientsWith 2019 NovelCoronavirus-InfectedPneumonia in Wuhan, China. JAMA. 2020.
• 23. Chinese Center forDisease Control andPrevention. GuidelinesforEpidemiologicalInvestigation of COVID-19 [EB/OL]. (inChinese) (2020-03-09)12020-03-15]. http: //www.chinacdc.cn/jkzt/crb/zl/szkb_ 11803/jszl_ 11815/202003/120200309 214241.html.
• 24.Zhao S, Musa SS, Lin Q, et al. EstimatingtheUnreportedNumber of NovelCoronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-DrivenModelling Analysis of theEarlyOutbreak. J ClinMed. 2020;9:2.
• 25. Mahase E. ChinaCoronavirus: what do weknowso far? BMJ. 2020;368:308.
• 26.Li Q, Guan X, Wu P, et al. EarlyTransmission Dynamics in Wuhan, China, of NovelCoronavirus-InfectedPneumonia. N Engl J Med. 2020.
• 27.Huang C, Wang Y, Li X, et al. Clinicalfeatures of patientsinfectedwith 2019 novelCoronavirus in Wuhan, China. Lancet. 2020.
• 28.https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-current-situation/covid-19-current-cases, (Erişim Tarihi 29.04.2020)